These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

384 related items for PubMed ID: 9416842

  • 1. Changes in p53 expression can modify cell shape of ras-transformed fibroblasts and epitheliocytes.
    Gloushankova N, Ossovskaya V, Vasiliev J, Chumakov P, Kopnin B.
    Oncogene; 1997 Dec 11; 15(24):2985-9. PubMed ID: 9416842
    [Abstract] [Full Text] [Related]

  • 2. Influence of exogenous ras and p53 on P-glycoprotein function in immortalized rodent fibroblasts.
    Kopnin BP, Stromskaya TP, Kondratov RV, Ossovskaya VS, Pugacheva EN, Rybalkina EY, Khokhlova OA, Chumakov PM.
    Oncol Res; 1995 Dec 11; 7(6):299-306. PubMed ID: 8527864
    [Abstract] [Full Text] [Related]

  • 3. [The effect of the tumor suppressor p53 and its mutant forms on the differentiation and viability of K562 leukemic cells].
    Kremenetskaia OS, Logacheva NP, Baryshnikov AIu, Chumakov PM, Kopnin BP.
    Tsitologiia; 1996 Dec 11; 38(12):1280-93. PubMed ID: 9163103
    [Abstract] [Full Text] [Related]

  • 4. [Opposite effect of p53 on nucleotide metabolizing enzyme activity in Rat1 cells and their sublines, transformed by N-RAS or v-mos oncogenes].
    Khramtsova SN, Osovskaia VS, Semeniak OIu, Potapova GI, Chumakov PM, Kopnin BP.
    Biokhimiia; 1995 Nov 11; 60(11):1881-8. PubMed ID: 8590759
    [Abstract] [Full Text] [Related]

  • 5. P53-dependent effects of RAS oncogene on chromosome stability and cell cycle checkpoints.
    Agapova LS, Ivanov AV, Sablina AA, Kopnin PB, Sokova OI, Chumakov PM, Kopnin BP.
    Oncogene; 1999 May 20; 18(20):3135-42. PubMed ID: 10340385
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Responses of epithelial and fibroblast-like cells to discontinuous configuration of the culture substrate.
    Rovensky YuA, Domnina LV, Ivanova OYu, Vasiliev JM.
    Membr Cell Biol; 2001 Jul 20; 14(5):617-27. PubMed ID: 11699865
    [Abstract] [Full Text] [Related]

  • 14. [The protective role of p53 in Ras-induced transformation of REF52 cells].
    Kopnin PB, Ivanov AV, Il'inskaia GV, Sablina AA, Kopnin BP, Chumakov PM.
    Mol Biol (Mosk); 2003 Jul 20; 37(3):458-71. PubMed ID: 12815953
    [Abstract] [Full Text] [Related]

  • 15. Suppression of the tumorigenicity of mutant p53-transformed rat embryo fibroblasts through expression of a newly cloned rat nonmuscle myosin heavy chain-B.
    Yam JW, Chan KW, Hsiao WL.
    Oncogene; 2001 Jan 04; 20(1):58-68. PubMed ID: 11244504
    [Abstract] [Full Text] [Related]

  • 16. NF-kappa B is required for H-ras oncogene induced abnormal cell proliferation and tumorigenesis.
    Jo H, Zhang R, Zhang H, McKinsey TA, Shao J, Beauchamp RD, Ballard DW, Liang P.
    Oncogene; 2000 Feb 17; 19(7):841-9. PubMed ID: 10702792
    [Abstract] [Full Text] [Related]

  • 17. Cylindrical substratum induces different patterns of actin microfilament bundles in nontransformed and in ras-transformed epitheliocytes.
    Levina EM, Domnina LV, Rovensky YA, Vasiliev JM.
    Exp Cell Res; 1996 Nov 25; 229(1):159-65. PubMed ID: 8940260
    [Abstract] [Full Text] [Related]

  • 18. Transformation-selective apoptotic program triggered by farnesyltransferase inhibitors requires Bin1.
    DuHadaway JB, Du W, Donover S, Baker J, Liu AX, Sharp DM, Muller AJ, Prendergast GC.
    Oncogene; 2003 Jun 05; 22(23):3578-88. PubMed ID: 12789266
    [Abstract] [Full Text] [Related]

  • 19. The properties of p53 proteins selected for the loss of suppression of transformation.
    Olson DC, Levine AJ.
    Cell Growth Differ; 1994 Jan 05; 5(1):61-71. PubMed ID: 8123594
    [Abstract] [Full Text] [Related]

  • 20. Transformation by RAS oncogene decreases the width of substrate-spread fibroblasts but not their length.
    Kharitonova MA, Kopnin PB, Vasiliev JM.
    Cell Biol Int; 2007 Mar 05; 31(3):220-3. PubMed ID: 17142064
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.